Quantum Genomics to give an exclusive license for firibastat in South-East Asia, Australia and New Zealand Quantum Genomics to give an exclusive license for firibastat in South-East Asia, Australia and New Zealand. Read the press realease Previous Post (p) Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension Next Post (n) Quantum Genomics Reports First Half 2020 Financial Results
